Latest Breaking News On - Verve therapeutics - Page 3 : comparemela.com

VERV Stock Earnings: Verve Therapeutics Beats EPS, Beats Revenue for Q1 2024

VERV Stock Earnings: Verve Therapeutics Beats EPS, Beats Revenue for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Verve therapeuticsPlace earnings

Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial

Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSekar kathiresanAshlea kosikowskiJen robinsonExchange commissionVerve therapeutics incClinical trial applicationsTrial applicationsVerve therapeuticsPrivate securities litigation reform act

S&P 500: Only One ETF Is Doing Even Worse Than Cathie Wood s | Investor s Business Daily

S&P 500: Only One ETF Is Doing Even Worse Than Cathie Wood s | Investor s Business Daily
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

United statesMenlo parkPhilip blancatoCathie woodProshares russellInvesco russellPacific biosciencesFluence energyDaily base currencyWilderhill clean energyInvesco wilderhill clean energyHill clean energyLadenburg thalmann asset managementWilderhill cleanInvesco wilderhillVerve therapeutics

Vestmark Advisory Solutions Inc Purchases New Holdings in Verve Therapeutics, Inc (NASDAQ:VERV)

Vestmark Advisory Solutions Inc Purchases New Holdings in Verve Therapeutics, Inc (NASDAQ:VERV)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesStifel nicolausHermes incVanguard group incExchange commissionInvestment managementVestmark advisory solutions incSumitomo mitsui trust holdings incVerve therapeutics incRoyal bankVestmark advisory solutionsVerve therapeuticsFree reportAdvisory solutionsSumitomo mitsui trust holdingsMitsui trust holdings

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BOSTON, May 03, 2024 Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today.

United statesJen robinsonAshlea kosikowskiVerve therapeutics incStock incentive planNasdaq listing ruleVerve therapeutics